TITLE:
GL701 (Prestara) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids

CONDITION:
Systemic Lupus Erythematosus

INTERVENTION:
Prasterone (GL701)

SUMMARY:

      Open label safety and efficacy follow-up.
    

DETAILED DESCRIPTION:

      This was a randomized, multi-center, open-label, parallel-group, trial of prasterone 200 or
      100 mg/day for 12 months in women with lupus receiving glucocorticoid therapy who had
      completed an earlier 6-month randomized, placebo-controlled study (NCT00053560. Bone Mineral
      Density assessments were performed at baseline and at months 6 and 12.
    

ELIGIBILITY:
Gender: Female
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Patient has completed the full 6 month treatment period with study drug in the
             previous Genelabs' clinical study GL02-01.

          -  Concomitant treatment with prednisone (or equivalent) at a dose of  5mg/day.

          -  Patient has read and signed an Informed Consent Form. If the patient is not fluent in
             English, the Informed Consent must be signed in her native language.

        Exclusion Criteria:

          -  Patient has had a serious study drug related adverse reaction at any time during the
             previous GL02-01 study.

          -  Any condition which in the Investigator's or Sponsor's opinion is sufficient to
             prevent adequate compliance with the study or likely to confuse follow-up evaluation
             (e.g., alcoholism, drug addiction, acute withdrawal from chemical dependency,
             psychiatric disease).

        MEDICATIONS PROHIBITED AT ANY TIME DURING THE STUDY

          -  Calcitonin

          -  Bisphosphonates

          -  Fluoride at pharmacologic dose

          -  Strontium at pharmacologic dose

          -  Estrogenic steroids (except oral contraceptives)

          -  Selective Estrogen Receptor Modulator (raloxifene)

          -  Parathyroid hormone

          -  Any androgens, including prescription or nutritional supplement DHEA, other than
             study drug

          -  Additional Calcium supplements other than those prescribed as part of this study
      
